UK's Medicines and Healthcare products Regulatory Agency pragmatic over cellphone interference risk
This article was originally published in Clinica
Executive Summary
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is opting for pragmatism in its approach to the use of mobile phones in clinical settings, in light of the electromagnetic interference that can affect the performance of some medical equipment.